BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 15177472)

  • 21. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida).
    Santoro GF; Cardoso MG; Guimarães LG; Freire JM; Soares MJ
    Parasitology; 2007 Oct; 134(Pt 11):1649-56. PubMed ID: 17686189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.
    de Souza EM; Oliveira GM; Boykin DW; Kumar A; Hu Q; De Nazaré C Soeiro M
    J Antimicrob Chemother; 2006 Sep; 58(3):610-4. PubMed ID: 16854954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
    Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
    J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease.
    Marín C; Ramírez-Macías I; López-Céspedes A; Olmo F; Villegas N; Díaz JG; Rosales MJ; Gutiérrez-Sánchez R; Sánchez-Moreno M
    J Nat Prod; 2011 Apr; 74(4):744-50. PubMed ID: 21466157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
    Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
    Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
    DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
    Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas' disease.
    Senkovich O; Bhatia V; Garg N; Chattopadhyay D
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3234-8. PubMed ID: 16048931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant metabolites active against Trypanosoma cruzi.
    Sepúlveda-Boza S; Cassels BK
    Planta Med; 1996 Apr; 62(2):98-105. PubMed ID: 8657759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
    Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
    Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
    J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
    Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S
    Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi.
    Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM
    Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
    Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
    Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
    Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
    Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
    Villarreal D; Barnabé C; Sereno D; Tibayrenc M
    Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neolignans from plants in northeastern Brazil (Lauraceae) with activity against Trypanosoma cruzi.
    Cabral MM; Barbosa-Filho JM; Maia GL; Chaves MC; Braga MV; De Souza W; Soares RO
    Exp Parasitol; 2010 Mar; 124(3):319-24. PubMed ID: 19944690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.
    Singh PK; Jones MM; Lane JE; Nesset A; Zimmerman LJ; Ribeiro-Rodrigues R; Richter A; Stenger MR; Carter CE
    Arzneimittelforschung; 1997 Mar; 47(3):311-5. PubMed ID: 9105552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
    Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H
    Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.